Evidence map›Paper›PMID 25640082›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2015

Parameters of dynamic contrast-enhanced MRI as imaging markers for angiogenesis and proliferation in human breast cancer.

Lin Li, Kai Wang, Xilin Sun, Kezheng Wang, Yingying Sun, Guangfeng Zhang, Baozhong Shen

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 1 pooled it
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 1 synthesis or guideline pooled it, 127 citations in OpenAlex.

  1. Pooled it
  2. Hyperbaric oxygen can induce angiogenesis and recover erectile function.International journal of impotence research · 2018
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Lin LiDepartment of Radiology, Fourth Hospital of Harbin Medical University, Harbin, Heilongjiang, China (mainland).
Kai WangMolecular Imaging Center, Harbin Medical University, Harbin, Heilongjiang, China (mainland).
Xilin SunMolecular Imaging Center, Harbin Medical University, Harbin, Heilongjiang, China (mainland).
Kezheng WangMolecular Imaging Center, Harbin Medical University, Harbin, Heilongjiang, China (mainland).
Yingying SunMolecular Imaging Center, Harbin Medical University, Harbin, Heilongjiang, China (mainland).
Guangfeng ZhangDepartment of Radiology, Fourth Hospital of Harbin Medical University, Harbin, Heilongjiang, China (mainland).
Baozhong ShenDepartment of Radiology, Fourth Hospital of Harbin Medical University, Harbin, Heilongjiang, China (mainland).
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer is the most common malignancy and the leading cause of cancer death in women worldwide; however, early diagnosis has been difficult due to its complex pathological structure. This study evaluated the value of morphological examination in conjunction with dynamic contrast-enhanced MRI (DCE-MRI) for more precise diagnosis of breast cancer, as well as their correlation with angiogenesis and proliferation biomarkers. MATERIAL/

methodsDCE-MRI parameters (including Ktrans: volume transfer coefficient reflecting vascular permeability, Kep: flux rate constant, Ve: extracellular volume ratio reflecting vascular permeability, and ADC: apparent diffusion coefficient) were obtained from 124 patients with breast cancer (124 lesions). Microvessel density (MVD) was evaluated by the immunohistochemical analysis of tumor vessels for CD31 and CD105 expression. The proliferation was assessed by analyzing Ki67.

resultsKtrans values were in the order of: malignant lesions>benign lesions>normal glands. Similar results were observed for Kep. The opposite changes were seen with Ve. Ktrans and Kep values were significantly higher in invasive ductal carcinoma (IDC) and ductal carcinoma in situ (DCIS) than in mammary ductal dysplasia (MDD; ANOVA followed by Dunnett's test). In sharp contrast, ADC values were lower in IDC and DCIS than in MDD, and Ve was not significantly different among the three groups. The data from MIP (maximum intensity projection) showed that benign breast lesions had no or only one blood vessel, whereas malignant lesions had two or more blood vessels. In addition, expression of CD105 and Ki67, the commonly recognized markers for angiogenesis and proliferation, respectively, were closely correlated with MRI parameters as revealed by Pearson analysis.

conclusionsDetermination of Ktrans, Kep and ADC values permits estimation of tumor angiogenesis and proliferation in breast cancer and DCE-MRI parameters can be used as imaging biomarkers to predict patient prognosis and the biologic aggressiveness of the tumor.

Indexed as

AdultAgedAntigens, CDBiomarkersBreast NeoplasmsCell ProliferationContrast MediaEndoglinFemaleHumansImmunohistochemistryKi-67 AntigenMagnetic Resonance ImagingMiddle AgedNeovascularization, PathologicPermeabilityAntigens, CDBiomarkersContrast MediaEndoglinENG protein, humanKi-67 AntigenPlatelet Endothelial Cell Adhesion Molecule-1Receptors, Cell Surface

Identifiers

PMID25640082
PMCPMC4324575
OpenAlexW2012573772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.